ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      18,998.80
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      81.875
      -2.62%
      Bitcoin
      66,980.65
      4.71%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Calidi Biotherapeutics Inc (CLDI) Quote

      Calidi Biotherapeutics Inc

      Calidi Biotherapeutics Inc (CLDI)

      AMEX
      1.76
      0.13
      (7.98%)
      At close: July 19 4:00PM
      Delayed by 15 minutes
      1.7682
      0.0082
      ( 0.47% )
      After Hours: 6:03PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.7682
      Bid
      -
      Ask
      -
      Volume
      932,587
      1.73 Day's Range 1.95
      1.414 52 Week Range 50.00
      Market Cap
      10.463M
      Previous Close
      1.63
      Open
      1.80
      Last Trade
      20
      @
      1.7697
      Last Trade Time
      18:07:22
      Financial Volume
      $ 1,681,155
      VWAP
      1.8027
      Average Volume (3m)
      1,634,504
      Shares Outstanding
      6,419,114
      Dividend Yield
      -
      PE Ratio
      -0.39
      Earnings Per Share (EPS)
      -4.55
      Revenue
      -
      Net Profit
      -29.22M

      About Calidi Biotherapeutics Inc

      The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.calidibio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Calidi Biotherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CLDI. The last closing price for Calidi Biotherapeutics was $1.63. Over the last year, Calidi Biotherapeutics shares have traded in a share price range of $ 1.414 to $ 50.00.

      Calidi Biotherapeutics currently has 6,419,114 shares outstanding. The market capitalization of Calidi Biotherapeutics is $10.46 million. Calidi Biotherapeutics has a price to earnings ratio (PE ratio) of -0.39.

      CLDI Latest News

      More News

      Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

      SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

      July 18 2024
      GlobeNewswire Inc.

      Calidi to Effect Reverse Stock Split

      Calidi common stock expected to begin trading on a 1-for-10 split adjusted basis on July 15, 2024 Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or “Company”), a clinical-stage...

      July 05 2024
      Business Wire

      Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

      Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the...

      June 27 2024
      Business Wire

      Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

      Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to...

      June 11 2024
      Business Wire

      Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

      Calidi’s best-in-class, novel systemic targeted virotherapy program (RTNova) aims to provide a feasible solution to target disseminated tumors with a systemic administration -- a long-pursued...

      June 10 2024
      Business Wire

      Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

      - NeuroNova (CLD-101) Phase 1 update highlights enrollment progress, safety and feasibility in delivering up to four weekly doses of CLD-101 - Showcased preclinical data on RTNova (CLD-400...

      June 03 2024
      Business Wire

       Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

      Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the...

      May 31 2024
      Business Wire

      Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

      Three upcoming posters, including an update from ongoing Phase 1 trial of Calidi’s CLD-101 program, to be presented at 2024 ASCO Annual Meeting Presented new data on the mechanisms of action of...

      May 14 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.168210.51251.62.18371.446588981.70382709CS
      4-0.1518-7.906251.922.1981.4148625611.72407241CS
      120.14629.013563501851.6224.91.41416345042.14095489CS
      26-10.7318-85.854412.516.81.41410666323.18549591CS
      52-43.3318-96.079379157445.1501.4146543184.03321194CS
      156-43.3318-96.079379157445.1501.4146543184.03321194CS
      260-43.3318-96.079379157445.1501.4146543184.03321194CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CISOCISO Global Inc
      $ 0.8397
      (41.13%)
      		2.25M
      NCPLNetcapital Inc
      $ 0.1389
      (33.56%)
      		13.32M
      NUZENuZee Inc
      $ 1.38
      (21.17%)
      		3.17k
      CMAXCareMax Inc
      $ 1.8393
      (16.41%)
      		8.6k
      SPGCSacks Parente Golf Inc
      $ 0.61
      (15.09%)
      		242.66k
      XCURExicure Inc
      $ 0.3879
      (-27.51%)
      		5.9M
      PRTGPortage Biotech Inc
      $ 0.1938
      (-15.41%)
      		5.17M
      IONMAssure Holdings Corporation
      $ 2.79
      (-10.00%)
      		21.94k
      SGDSafe and Green Development Corporation
      $ 0.3304
      (-8.48%)
      		79.13k
      SXTP60 Degrees Pharmaceuticals Inc
      $ 0.2489
      (-8.15%)
      		2.89M
      NCPLNetcapital Inc
      $ 0.1389
      (33.56%)
      		13.32M
      SERVServe Robotics Inc
      $ 8.50
      (12.58%)
      		9.97M
      XCURExicure Inc
      $ 0.3879
      (-27.51%)
      		5.9M
      PRTGPortage Biotech Inc
      $ 0.1938
      (-15.41%)
      		5.17M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.2143
      (-0.60%)
      		4.63M

      CLDI Discussion

      View Posts
      ErnieBilco ErnieBilco 2 weeks ago
      Probably because it is a worthless company that is heavily in debt and by all rights it should be kicked off the Nasdaq but Nasdaq urges these worthless companies to screw their shareholders to artificially get their stock price to $1 - I expect a landslide decline back to a quarter in short order.

      This is one of my bets that doesn't look like it will make me any money - unless they can somehow pump it up on the fact the the OS will be about 5 million shares on split day.

      Just my take on it after looking thru Q1 Quarterly report.
      👍️0
      JTORENCE JTORENCE 2 weeks ago
      Ernie Bilco You may have predicted right. Reverse splits are usually the death blow for a stock. Hope not. Why did they do this??
      👍️0
      Invest-in-America Invest-in-America 1 month ago
      CLDI: News --- collaboration with SIGA to kill all Cancers.
      👍️0
      Termite7 Termite7 2 months ago
      Keeping an eye...... coiled!!!
      👍️0
      accipiterr accipiterr 2 months ago
      April 24th webinar
      https://redchip.zoom.us/webinar/register/WN_qT-PBRbTQ0yLeBbJ4jzPSw
      in this one they mention 3 different times that they are talking to large pharmaceutical companies about licencing and about how the recent data, specifically for RTnova, has resulted in high level discussions with more planned in the near future.


      May 9th webinar
      https://sidoti.zoom.us/webinar/register/WN_p8GBAbbqTd2OuYnM33eTuQ#/registration
      👍️0
      accipiterr accipiterr 2 months ago
      Bottom in, looks ready for a move up. Data being presented on June 1st.
      👍️0
      ErnieBilco ErnieBilco 3 months ago
      Yikes, RedChip is usually the kiss of death for all the stocks they have pumped or paid promoted
      👍️0
      Legend431 Legend431 3 months ago
      Looking good
      👍️0
      Triple nickle Triple nickle 3 months ago
      Here we gooooo
      👍️0
      2020trader 2020trader 3 months ago
      DOWN 6% TODAY....EXPECTING LOWER
      👍️0
      glenn1919 glenn1919 5 months ago
      CLDI................................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
      👍️0

      Your Recent History

      AMEX
      CLDI
      Calidi Biotherapeutics
      KOSPI
      001560
      Cheil Grinding Wheel Ind
      BIT
      UC2X1A
      Unicredit Bank
      TSXV
      VIS
      Visionstate
      Delayed Upgrade Clock